Mahickra Chemicals Ltd (MAHICKRA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Mahickra Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Significant movement in price has been observed in Mahickra Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Others (Uncategorized) · 02 Nov 2026, 10:18 pm
Mahickra Chemicals Limited has informed the Exchange regarding Resignation of Mr Niren Desai as Independent Director of the company w.e.f. October 31, 2026.
Outcome · 01 Nov 2026, 12:10 am
Mahickra Chemicals H1 FY27 Results and Board Updates For the half-year ended 30th Sep'26, Mahickra Chemicals reported consolidated revenue from operations of ₹5,836.73 lakhs, up 18.99% YoY from ₹4,905.29 lakhs. Consolidated net profit surged 250.66% YoY to ₹318.50 lakhs from ₹90.83 lakhs, with basic EPS rising to ₹3.26 from ₹1.12. Out of ₹2,596.39 lakhs raised via preferential issue, ₹1,972.04 lakhs was utilized and ₹624.35 lakhs remained unutilized as of 30th Sep'26. Additionally, Independent Director Niren Desai resigned effective 31st Oct'26 due to other professional commitments.
Mahickra Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 01 Nov 2026, 12:07 am
Mahickra Chemicals Reports H1 FY27 Results; Consolidated Net Profit Jumps 251% YoY Mahickra Chemicals reported consolidated revenue from operations of ₹5,836.73 lakhs for the half-year ended 30th Sep'26, up 18.99% YoY from ₹4,905.29 lakhs. Consolidated net profit surged 250.65% YoY to ₹318.50 lakhs compared to ₹90.83 lakhs in H1 FY26, with EPS rising to ₹3.26 from ₹1.12. Standalone revenue and PAT stood at ₹5,836.73 lakhs and ₹318.56 lakhs, respectively. Additionally, Independent Director Niren Desai resigned effective 31st Oct'26 due to other professional commitments, and ₹624.35 lakhs of preferential issue proceeds remained unutilized as of 30th Sep'26.
Mahickra Chemicals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 31 Oct 2026, 5:30 am
Mahickra Chemicals Schedules Board Meeting to Consider Half-Yearly Results Mahickra Chemicals Limited announced that a meeting of its Board of Directors is scheduled for 31st Oct'26. The board will convene primarily to consider and approve the company's un-audited financial results for the half-year period ended Sep'26, alongside other general business matters.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 31 Oct 2026, 5:30 am
Mahickra Chemicals Schedules Board Meeting to Approve H1 FY27 Results Mahickra Chemicals has scheduled a Board of Directors meeting on 31st Oct'26 to consider and approve the un-audited standalone and consolidated financial results for the half year ended Sep'26. Additionally, in compliance with SEBI insider trading regulations, the trading window for dealing in company equity shares has been closed since 1st Oct'26 and will reopen 48 hours post the official declaration and submission of the financial results to the stock exchange.
Mahickra Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 17, 2026.
Outcome · 17 Oct 2026, 10:20 pm
Mahickra Chemicals Approves 51% Majority Stake Acquisition in Vida Wellness Mahickra Chemicals' Board approved acquiring a 51% controlling stake in Vida Wellness Pvt Ltd on 17th Oct'26 for ₹53.18 lakh via rights issue subscription of 2,65,898 equity shares at ₹20 each. The cash transaction diversifies operations into wellness, disposable hygiene, and personal care segments within an estimated 60-day timeframe. Vida Wellness posted declining turnovers of ₹777.64 lakh in FY23, ₹520.32 lakh in FY24, and ₹388.10 lakh in FY25. The non-related-party deal requires no governmental approvals.
To consider acquisition of equity shares of Vida Wellness Private Limited by Mahickra Chemicals Limited and other business matters
Intimation · 17 Oct 2026, 5:30 am
Mahickra Chemicals Board to Consider Acquisition of Vida Wellness Mahickra Chemicals Limited has scheduled a Board of Directors meeting on 17th Oct'26 to evaluate and consider the acquisition of equity shares in Vida Wellness Private Limited. Consequently, the company's trading window for dealing in equity shares, which has been closed since 1st Oct'26, will continue to remain shut and will reopen 48 hours after the declaration of un-audited financial results for the half-year ended 30th Sep'26.
Mahickra Chemicals Limited has submitted the Exchange a copy Srutinizers report of undefined held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 06 Oct 2026, 4:37 am
Mahickra Chemicals Shareholders Approve All 10 Resolutions at 9th AGM Mahickra Chemicals Limited announced the voting results for its 9th AGM held on 30th Sep'26, with all 10 resolutions passed with 100% approval of valid votes polled. Key approved items include the adoption of FY26 financial statements, the re-appointment of Managing Director Miteshkumar Gandhi and Whole-Time Directors Ashishkumar Gandhi and Komal Gandhi along with their remuneration, material related-party transactions with Palash Colours and Arham Exports, personal guarantee modifications, independent director reappointment, and variation in objects for utilizing preferential issue proceeds. Total voter turnout stood at 30.47% across 2.98m shares polled.
Mahickra Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 30 Sept 2026, 10:00 pm
Mahickra Chemicals Limited has informed the Exchange about Book Closure of the 09th Annual General Meeting
Annual General Meeting · 06 Sept 2026, 12:23 am
Mahickra Chemicals Limited has informed the Exchange about providing a web-link of the Annual Report for the Financial Year 2025-26 sentto those Members who have not registered their e-mail addresses with the Registrar and TransferAgents/Depositories.
Annual Report · 06 Sept 2026, 12:14 am
Mahickra Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 05 Sept 2026, 11:52 pm
The Exchange had sought clarification from Mahickra Chemicals Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Others (Uncategorized) · 16 Jul 2026, 10:47 pm
Mahickra Chemicals Clarifies Discrepancies in XBRL Financial Filings Mahickra Chemicals, in a clarification dated Jul 02, '26, stated that discrepancies in its XBRL financial filings were due to inadvertent clerical errors. The issues included a mismatch in consolidated EPS and non-disclosure of "Reserves excluding Revaluation Reserve" in the standalone XBRL. The company confirmed there are no changes to the PDF financial results approved by the Board on May 30, '26. The firm has since rectified the errors by submitting a revised Integrated XBRL and has strengthened its internal review processes.
The Exchange has sought clarification from Mahickra Chemicals Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Others (Uncategorized) · 27 Jun 2026, 6:20 pm